Pavion Blue Capital’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Sell
4,220
-492
-10% -$38.8K 0.13% 81
2025
Q4
$386K Sell
4,712
-315
-6% -$24.5K 0.16% 70
2025
Q3
$378K Sell
5,027
-15
-0.3% -$1.12K 0.16% 72
2025
Q2
$373K Sell
5,042
-211
-4% -$14.7K 0.17% 71
2025
Q1
$424K Sell
5,253
-16
-0.3% -$1.38K 0.2% 67
2024
Q4
$412K Sell
5,269
-1,215
-19% -$103K 0.19% 69
2024
Q3
$609K Sell
6,484
-69
-1% -$5.79K 0.28% 62
2024
Q2
$511K Sell
6,553
-16
-0.2% -$1.3K 0.25% 64
2024
Q1
$597K Sell
6,569
-8
-0.1% -$666 0.3% 59
2023
Q4
$509K Sell
6,577
-35
-0.5% -$2.45K 0.28% 61
2023
Q3
$450K Sell
6,612
-6
-0.1% -$437 0.27% 60
2023
Q2
$538K Buy
6,618
+40
+0.6% +$3.19K 0.31% 59
2023
Q1
$540K Buy
+6,578
New +$470K 0.33% 58

Other funds holding GEHC

Pavion Blue Capital's GEHC Position: Q1 2026 in Review

Pavion Blue Capital reduced its GE HealthCare (GEHC) stake by 10% in Q1 2026, selling an estimated $38.8K and leaving 4,220 shares worth $300K. The position accounts for 0.13% of the portfolio, ranked #81.

Pavion Blue Capital first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $609K in Q3 2024. 1,266 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Pavion Blue Capital held 4,220 shares of GE HealthCare worth $300K as of Q1 2026.
  • Pavion Blue Capital sold 492 GE HealthCare shares in Q1 2026, an estimated $38.8K.
  • GE HealthCare made up 0.13% of Pavion Blue Capital's portfolio in Q1 2026, its #81 holding.
  • Pavion Blue Capital first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Pavion Blue Capital's GE HealthCare position peaked at $609K in Q3 2024.
  • 1,266 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Pavion Blue Capital's 13F filing for Q1 2026, filed 6 May 2026.